These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11680988)

  • 1. [Irritable bowel syndrome: diagnostic criteria and recent advancement of its pharmacological management].
    Matsueda K
    Nihon Shokakibyo Gakkai Zasshi; 2001 Oct; 98(10):1146-53. PubMed ID: 11680988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serotonin may be the key to the treatment of "irritable bowel disease"].
    Sjövall H
    Lakartidningen; 2001 May; 98(18):2166-71. PubMed ID: 11402594
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel medications for the irritable bowel syndrome: motility and sensation.
    Camilleri M
    J Pediatr Gastroenterol Nutr; 2001; 32 Suppl 1():S35-7. PubMed ID: 11321419
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin receptor modulation in irritable bowel syndrome: one step forwards and one step backwards.
    Whorwell PJ
    Gut; 2001 May; 48(5):596-7. PubMed ID: 11302953
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs to treat irritable bowel syndrome being tested.
    Mayo Clin Health Lett; 2000 Mar; 18(3):4. PubMed ID: 10734837
    [No Abstract]   [Full Text] [Related]  

  • 6. Systematic review on the management of irritable bowel syndrome in North America.
    Brandt LJ; Bjorkman D; Fennerty MB; Locke GR; Olden K; Peterson W; Quigley E; Schoenfeld P; Schuster M; Talley N
    Am J Gastroenterol; 2002 Nov; 97(11 Suppl):S7-26. PubMed ID: 12425586
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotransmitter antagonism in management of irritable bowel syndrome.
    Lembo T
    Lancet; 2000 Mar; 355(9209):1030-1. PubMed ID: 10744083
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence-based position statement on the management of irritable bowel syndrome in North America.
    American College of Gastroenterology Functional Gastrointestinal Disorders Task Froce
    Am J Gastroenterol; 2002 Nov; 97(11 Suppl):S1-5. PubMed ID: 12425585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Irritable bowel syndrome as an interdisciplinary clinical challenge. Current views on its pathophysiology, diagnosis and treatment].
    Hollerbach S; Elsenbruch S; Enck P
    Dtsch Med Wochenschr; 2001 Apr; 126(16):472-8. PubMed ID: 11360454
    [No Abstract]   [Full Text] [Related]  

  • 10. Alosetron: a new therapy for irritable bowel syndrome.
    Kupecz D
    Nurse Pract; 2000 Jul; 25(7):95-6, 98-100. PubMed ID: 10916831
    [No Abstract]   [Full Text] [Related]  

  • 11. Lotronex(tm): therapy for diarrhea predominant irritable bowel syndrome.
    McGahan L
    Issues Emerg Health Technol; 2000 Oct; (11):1-5. PubMed ID: 11902219
    [No Abstract]   [Full Text] [Related]  

  • 12. Irritable bowel syndrome and the role of 5-HT. Proceedings of a roundtable meeting. New Orleans, Louisiana, USA. May 1998.
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():1-82. PubMed ID: 10447353
    [No Abstract]   [Full Text] [Related]  

  • 13. The challenge of irritable bowel syndrome: creating an alliance between patient and physician.
    Shen B; Soffer E
    Cleve Clin J Med; 2001 Mar; 68(3):224-5, 229-33, 236-7. PubMed ID: 11263850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary thoughts on the treatment of irritable bowel syndrome.
    Giaquinta D
    Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
    [No Abstract]   [Full Text] [Related]  

  • 15. So what happened to alosetron?
    Hyams JS
    J Pediatr Gastroenterol Nutr; 2001 May; 32(5):513-4. PubMed ID: 11455947
    [No Abstract]   [Full Text] [Related]  

  • 16. Tegaserod and other serotonergic agents: what is the evidence?
    Chey WD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment.
    Olden KW
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S3-7. PubMed ID: 12825862
    [No Abstract]   [Full Text] [Related]  

  • 18. [Soon one "female distress" less. Irritable bowel syndrome responds to serotonin blockers].
    MMW Fortschr Med; 2000 Sep; 142(37):55. PubMed ID: 11026224
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 20. Alosetron for irritable bowel syndrome.
    Barbehenn E; Lurie P; Wolfe SM
    Lancet; 2000 Dec; 356(9246):2009-10. PubMed ID: 11130544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.